Resultados de la búsqueda 2041-2050 of 14727 for circadian rhythms

  1. Salud de la mujer Noticias de la Mayo Clinic

    Social isolation linked to biological age gap, higher mortality rate March 20, 2024, 07:00 p.m. CDT · What's lurking in your body? Mayo probes health risks of ...

  2. Salud de la mujer Fitness basics - Mayo Clinic

    Social isolation linked to biological age gap, higher mortality rate March 20, 2024, 07:00 p.m. CDT · What's lurking in your body? Mayo probes health risks of ...

  3. Salud de la mujer - Mayo Clinic

    Social isolation linked to biological age gap, higher mortality rate March 20, 2024, 07:00 p.m. CDT · What's lurking in your body? Mayo probes health risks of ...

  4. Salud de la mujer Noticias de la Mayo Clinic

    Social isolation linked to biological age gap, higher mortality rate March 20, 2024, 07:00 p.m. CDT · What's lurking in your body? Mayo probes health risks of ...

  5. Salud de la mujer Noticias de la Mayo Clinic

    Social isolation linked to biological age gap, higher mortality rate March 20, 2024, 07:00 p.m. CDT · What's lurking in your body? Mayo probes health risks of ...

  6. Salud de la mujer - Mayo Clinic

    Social isolation linked to biological age gap, higher mortality rate March 20, 2024, 07:00 p.m. CDT · What's lurking in your body? Mayo probes health risks of ...

  7. Salud de la mujer Noticias de la Mayo Clinic

    Social isolation linked to biological age gap, higher mortality rate March 20, 2024, 07:00 p.m. CDT · What's lurking in your body? Mayo probes health risks of ...

  8. Centro Pediátrico de Mayo Clinic

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...

  9. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  10. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...